“Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article”. Pak-Euro Journal of Medical and Life Sciences 9, no. 1 (March 31, 2026): 25–34. Accessed May 2, 2026. https://readersinsight.net/index.php/PJMLS/article/view/3417.